Literature DB >> 27473721

Inhaled milrinone for pulmonary hypertension in high-risk cardiac surgery: silver bullet or just part of a broader management strategy?

Joseph Bednarczyk1, Johann Strumpher2,3, Eric Jacobsohn2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27473721     DOI： 10.1007/s12630-016-0708-9

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   6.713


× No keyword cloud information.
  11 in total

Review 1.  Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta-analysis.

Authors:  Remy R Coeytaux; Kristine M Schmit; Bryan D Kraft; Andrzej S Kosinski; Alicea M Mingo; Lisa M Vann; Daniel L Gilstrap; C William Hargett; Brooke Heidenfelder; Rowena J Dolor; Douglas C McCrory
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

Review 2.  Pulmonary hypertension and right ventricular dysfunction: physiology and perioperative management.

Authors:  Johann Strumpher; Eric Jacobsohn
Journal:  J Cardiothorac Vasc Anesth       Date:  2011-05-26       Impact factor: 2.628

Review 3.  Perioperative right ventricular dysfunction.

Authors:  André Yvan Denault; Francois Haddad; Eric Jacobsohn; Alain Deschamps
Journal:  Curr Opin Anaesthesiol       Date:  2013-02       Impact factor: 2.706

4.  Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass.

Authors:  Y Lamarche; O Malo; E Thorin; A Denault; M Carrier; J Roy; L P Perrault
Journal:  J Thorac Cardiovasc Surg       Date:  2005-07       Impact factor: 5.209

5.  Preliminary experience with inhaled milrinone in cardiac surgery.

Authors:  Yoan Lamarche; Louis P Perrault; Simon Maltais; Karine Tétreault; Jean Lambert; André Y Denault
Journal:  Eur J Cardiothorac Surg       Date:  2007-04-02       Impact factor: 4.191

Review 6.  The management of acute pulmonary arterial hypertension.

Authors:  Gan Hui-li
Journal:  Cardiovasc Ther       Date:  2010-06-18       Impact factor: 3.023

Review 7.  Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group.

Authors:  Julien Magne; Philippe Pibarot; Partho P Sengupta; Erwan Donal; Raphael Rosenhek; Patrizio Lancellotti
Journal:  JACC Cardiovasc Imaging       Date:  2015-01

8.  Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis.

Authors:  Spencer J Melby; Marc R Moon; Brian R Lindman; Marci S Bailey; Laureen L Hill; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2011-06       Impact factor: 5.209

9.  Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial.

Authors:  André Y Denault; Ronald G Pearl; Robert E Michler; Vivek Rao; Steven S L Tsui; Rainald Seitelberger; Matt Cromie; Elisabet Lindberg; Andrea M D'Armini
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-03-21       Impact factor: 2.628

Review 10.  Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.

Authors:  Laura C Price; Stephen J Wort; Simon J Finney; Philip S Marino; Stephen J Brett
Journal:  Crit Care       Date:  2010-09-21       Impact factor: 9.097
View more
  1 in total

1.  The link between pulmonary hypertension and adverse renal transplant outcome may be renal venous hypertension.

Authors:  Hilary P Grocott
Journal:  Indian J Anaesth       Date:  2018-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.